0001768446-19-000002.txt : 20191023
0001768446-19-000002.hdr.sgml : 20191023
20191023113209
ACCESSION NUMBER: 0001768446-19-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20191023
DATE AS OF CHANGE: 20191023
EFFECTIVENESS DATE: 20191023
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eliem Therapeutics, Inc.
CENTRAL INDEX KEY: 0001768446
IRS NUMBER: 832273741
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-333123
FILM NUMBER: 191163142
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2500
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET
STREET 2: 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001768446
Eliem Therapeutics, Inc.
200 BERKELEY STREET
18TH FLOOR
BOSTON
MA
MASSACHUSETTS
02116
617-778-2500
DELAWARE
None
None
Corporation
true
2018
Andrew
Levin
200 Berkeley Street
18th Floor
Boston
MA
MASSACHUSETTS
02116
Executive Officer
Director
David-Alexandre
Gros
17511 Los Morros #2283
Ranchero Santa Fe
CA
CALIFORNIA
92067
Director
Simon
Tate
20 Station Road
Cambridge
X0
UNITED KINGDOM
CB1 2JD
Director
Valerie
Morisset
200 Berkeley Street
18th Floor
Boston
MA
MASSACHUSETTS
02116
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
true
0001567619-19-004873
2019-02-04
false
true
false
0
16302501
16302501
0
false
6
0
0
0
false
Eliem Therapeutics, Inc.
Andrew Levin
Andrew Levin
Chief Executive Officer
2019-10-23